# Preliminary Exploration on the Operational Standards of Insulin Pump Installation in Diabetes Clinic in China

Study · id `cardio:ct-nct04129424` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04129424](<https://clinicaltrials.gov/study/NCT04129424>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04129424

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

## Technical summary

Registry record NCT04129424. Randomized; no masking; primary purpose treatment. Start 2019-12-01 (anticipated); primary completion 2020-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT04129424, source copy `cardio:ctgov-nct04129424-2019-10-16`, retrieved 2026-10-26)
- Planned start: 2019-12-01 (anticipated) (ClinicalTrials.gov record NCT04129424, source copy `cardio:ctgov-nct04129424-2019-10-16`, retrieved 2026-10-26)
- Primary completion: 2020-12-01 (anticipated) (ClinicalTrials.gov record NCT04129424, source copy `cardio:ctgov-nct04129424-2019-10-16`, retrieved 2026-10-26)
- Completion: 2020-12-01 (anticipated) (ClinicalTrials.gov record NCT04129424, source copy `cardio:ctgov-nct04129424-2019-10-16`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04129424, source copy `cardio:ctgov-nct04129424-2019-10-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04129424-2019-10-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Preliminary Exploration on the Operational Standards of Insulin Pump Installation in Diabetes Clinic in China
- Condition: Type 1 Diabetes Mellitus
- Condition: Type 2 Diabetes Mellitus
- Condition: Gestational Diabetes Mellitus
- Condition: Pancreatogenic Diabetes Mellitus
- Condition: Pregestational Diabetes Mellitus
- Condition: Diabetes Patients in Perioperative Period
- Intervention (Device): Insulin pump (Microtech, Equil®)
- Lead sponsor: Peking Union Medical College Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Peking Union Medical College Hospital (`cardio:org-peking-union-medical-college-hospital`)

## Provenance

Content hash: 3c13b3265c67693870313850cefc9fd5b94dfdfc022099551aa15fc9b4a95713
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
